HomeKYTX • NASDAQ
add
Kyverna Therapeutics Inc
Previous close
$3.99
Day range
$3.92 - $4.42
Year range
$3.92 - $35.03
Market cap
189.41M USD
Avg Volume
290.03K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.58M | 263.04% |
Net income | -34.49M | -123.03% |
Net profit margin | — | — |
Earnings per share | -0.80 | — |
EBITDA | -37.74M | -137.83% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 321.59M | 316.16% |
Total assets | 339.20M | 266.75% |
Total liabilities | 36.49M | 53.83% |
Total equity | 302.71M | — |
Shares outstanding | 43.17M | — |
Price to book | 0.57 | — |
Return on assets | -27.60% | — |
Return on capital | -29.58% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -34.49M | -123.03% |
Cash from operations | -27.49M | -146.94% |
Cash from investing | 676.00K | 101.25% |
Cash from financing | -152.00K | -100.44% |
Net change in cash | -26.96M | 11.47% |
Free cash flow | -14.14M | — |
About
Founded
2018
Headquarters
Website
Employees
119
